These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7846752)

  • 1. Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight.
    Ducharme MP; Slaughter RL; Edwards DJ
    Ther Drug Monit; 1994 Oct; 16(5):513-8. PubMed ID: 7846752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin pharmacokinetics in spinal cord injured patients: a comparison with age-matched, able-bodied controls.
    Lavezo LA; Davis RL
    J Spinal Cord Med; 1995 Oct; 18(4):233-5. PubMed ID: 8591068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of vancomycin in Japanese adult patients.
    Yasuhara M; Iga T; Zenda H; Okumura K; Oguma T; Yano Y; Hori R
    Ther Drug Monit; 1998 Apr; 20(2):139-48. PubMed ID: 9558127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance of Vancomycin Population-Predicted Pharmacokinetics with Patient-Specific Pharmacokinetics in Adult Hospitalized Patients: A Case Series.
    Onor IO; Neuliep A; Tran KA; Lambert J; Gillard CJ; Brakta F; Ezebuenyi MC; St James K; Okogbaa JI; Beyl RA
    Drugs R D; 2020 Jun; 20(2):83-93. PubMed ID: 32166646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing two predictive methods for determining serum vancomycin concentrations at a Veterans Affairs Medical Center.
    Lee E; Winter ME; Boro MS
    Am J Health Syst Pharm; 2006 Oct; 63(19):1872-5. PubMed ID: 16990634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of vancomycin in Thai patients.
    Purwonugroho TA; Chulavatnatol S; Preechagoon Y; Chindavijak B; Malathum K; Bunuparadah P
    ScientificWorldJournal; 2012; 2012():762649. PubMed ID: 22547995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infections.
    Pai MP; Cojutti P; Pea F
    Clin Pharmacokinet; 2015 Sep; 54(9):933-41. PubMed ID: 25850987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Vancomycin Prediction Methods Based on Estimated Creatinine Clearance or Trough Levels.
    Haeseker M; Croes S; Neef C; Bruggeman C; Stolk L; Verbon A
    Ther Drug Monit; 2016 Feb; 38(1):120-6. PubMed ID: 26418699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
    Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
    Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1-18 Years.
    Smit C; Goulooze SC; Brüggemann RJM; Sherwin CM; Knibbe CAJ
    AAPS J; 2021 Apr; 23(3):53. PubMed ID: 33839974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.
    Leader WG; Tsubaki T; Chandler MH
    Am J Hosp Pharm; 1994 Sep; 51(17):2125-30. PubMed ID: 7985687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin dosing in morbidly obese patients.
    Bauer LA; Black DJ; Lill JS
    Eur J Clin Pharmacol; 1998 Oct; 54(8):621-5. PubMed ID: 9860149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer dosing program for the initiation of vancomycin therapy.
    Ito MK; Duren LL; Simonian JS; Dreyfus-Vigil SD; Cookson TL
    Clin Pharm; 1993 Feb; 12(2):126-30. PubMed ID: 8453861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of vancomycin pharmacokinetics in hospitalized elderly and young patients using a Bayesian forecaster.
    Guay DR; Vance-Bryan K; Gilliland S; Rodvold K; Rotschafer J
    J Clin Pharmacol; 1993 Oct; 33(10):918-22. PubMed ID: 8227461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
    Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional range of creatinine clearance for renal drug dosing: a practical solution to the controversy of which weight to use in the Cockcroft-Gault equation.
    Brown DL; Masselink AJ; Lalla CD
    Ann Pharmacother; 2013; 47(7-8):1039-44. PubMed ID: 23757387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.
    Kirkpatrick CM; Duffull SB; Begg EJ
    Br J Clin Pharmacol; 1999 Jun; 47(6):637-43. PubMed ID: 10383541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of vancomycin and dosing recommendations for trauma patients.
    Medellín-Garibay SE; Ortiz-Martín B; Rueda-Naharro A; García B; Romano-Moreno S; Barcia E
    J Antimicrob Chemother; 2016 Feb; 71(2):471-9. PubMed ID: 26568565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.